Skip to main content

Published locations for Once-daily oral JAK inhibitor for atopic dermatitis effective in phase 3 study

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Once-daily oral JAK inhibitor for atopic dermatitis effective in phase 3 study

User login

  • Reset your password
  • /content/once-daily-oral-jak-inhibitor-atopic-dermatitis-effective-phase-3-study
  • /edermatologynews/article/210418/atopic-dermatitis/once-daily-oral-jak-inhibitor-atopic-dermatitis
  • /familypracticenews/article/210418/atopic-dermatitis/once-daily-oral-jak-inhibitor-atopic-dermatitis
  • /internalmedicinenews/article/210418/atopic-dermatitis/once-daily-oral-jak-inhibitor-atopic
  • /pediatricnews/article/210418/atopic-dermatitis/once-daily-oral-jak-inhibitor-atopic-dermatitis
  • /pediatrics/article/210418/atopic-dermatitis/once-daily-oral-jak-inhibitor-atopic-dermatitis
  • /internalmedicine/article/210418/atopic-dermatitis/once-daily-oral-jak-inhibitor-atopic-dermatitis
  • /dermatology/article/210418/atopic-dermatitis/once-daily-oral-jak-inhibitor-atopic-dermatitis
  • /familymedicine/article/210418/atopic-dermatitis/once-daily-oral-jak-inhibitor-atopic-dermatitis